137 related articles for article (PubMed ID: 6186369)
1. Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity.
Fry DW; Anderson LA; Borst M; Goldman ID
Cancer Res; 1983 Mar; 43(3):1087-92. PubMed ID: 6186369
[No Abstract] [Full Text] [Related]
2. Synthesis and retention of methotrexate polyglutamates in Ehrlich ascites carcinoma cells.
Balińska M
Drugs Exp Clin Res; 1986; 12(6-7):551-4. PubMed ID: 2427298
[TBL] [Abstract][Full Text] [Related]
3. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
[TBL] [Abstract][Full Text] [Related]
4. Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro.
Yalowich JC; Fry DW; Goldman ID
Cancer Res; 1982 Sep; 42(9):3648-53. PubMed ID: 6179605
[No Abstract] [Full Text] [Related]
5. Polyglutamation of methotrexate. Is methotrexate a prodrug?
Chabner BA; Allegra CJ; Curt GA; Clendeninn NJ; Baram J; Koizumi S; Drake JC; Jolivet J
J Clin Invest; 1985 Sep; 76(3):907-12. PubMed ID: 2413074
[No Abstract] [Full Text] [Related]
6. Effects of 2,4-dinitrophenol and other metabolic inhibitors on the bidirectional carrier fluxes, net transport, and intracellular binding of methotrexate in Ehrlich ascites tumor cells.
Fry DW; White JC; Goldman ID
Cancer Res; 1980 Oct; 40(10):3669-73. PubMed ID: 7438050
[No Abstract] [Full Text] [Related]
7. Augmentation of the intracellular levels of polyglutamyl derivatives of methotrexate by vincristine and probenecid in Ehrlich ascites tumor cells.
Fry DW; Yalowich JC; Goldman ID
Cancer Res; 1982 Jul; 42(7):2532-6. PubMed ID: 6177396
[TBL] [Abstract][Full Text] [Related]
8. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
Matherly LH; Fry DW; Goldman ID
Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
[TBL] [Abstract][Full Text] [Related]
9. Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3':5'-monophosphate in the Ehrlich ascites tumor.
White JC; Carchman RA; Fry DW; Goldman ID
Cancer Res; 1980 Jul; 40(7):2400-4. PubMed ID: 6155994
[TBL] [Abstract][Full Text] [Related]
10. Regulation of methotrexate polyglutaminate formation in Ehrlich ascites carcinoma cells by endogenous folate pool.
Balińska M
Acta Biochim Pol; 1986; 33(1):31-7. PubMed ID: 2424199
[TBL] [Abstract][Full Text] [Related]
11. Recent concepts on the mechanism of action of methotrexate.
White JC
Cancer Treat Rep; 1981; 65 Suppl 1():3-12. PubMed ID: 7326663
[No Abstract] [Full Text] [Related]
12. Membrane transport considerations in high-dose methotrexate regimens with leucovorin rescue.
Goldman ID
Cancer Treat Rep; 1981; 65 Suppl 1():13-7. PubMed ID: 6173119
[No Abstract] [Full Text] [Related]
13. [On uptake of 5-FU, 6-MP and methotrexate by ehrlich ascites tumor cells in vitro].
Oriuchi T
Sapporo Igaku Zasshi; 1970 Jun; 37(6):255-67. PubMed ID: 5534721
[No Abstract] [Full Text] [Related]
14. The reversal of effects of methotrexate on toxicity and glucose transport reduction by thymidine in Ehrlich ascites tumor bearing mice.
Fung KP; Ng SW; Choy YM
Cancer Biochem Biophys; 1986 Oct; 8(4):249-56. PubMed ID: 3802046
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes.
Fry DW; Gewirtz DA; Yalowich JC; Goldman ID
Adv Exp Med Biol; 1983; 163():215-34. PubMed ID: 6193686
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells.
Skovsgaard T
Cancer Res; 1978 Dec; 38(12):4722-7. PubMed ID: 719649
[No Abstract] [Full Text] [Related]
17. [Evaluation of biochemical criteria for sensitivity of tumor cells to methotrexate by means of mathematic simulation].
Belousova AK; Gerasimova GK; Vorontsov IN; Greshilov MM
Biokhimiia; 1980 Apr; 45(4):609-21. PubMed ID: 6769505
[TBL] [Abstract][Full Text] [Related]
18. Efflux of methotrexate and its polyglutamate derivatives from hepatic cells in vitro.
Balińska M; Galivan J; Coward JK
Cancer Res; 1981 Jul; 41(7):2751-6. PubMed ID: 6166369
[No Abstract] [Full Text] [Related]
19. [Biochemistry of cytotoxicity of amethopterin (author's transl)].
Manteuffel-Cymborowska M
Postepy Biochem; 1978; 24(1):93-115. PubMed ID: 652668
[No Abstract] [Full Text] [Related]
20. Some considerations in the experimental approach to distinguishing between membrane transport and intracellular disposition of antineoplastic agents, with specific reference to fluorodeoxyuridine, actinomycin D, and methotrexate.
Goldman D; Bowen D; Gewirtz DA
Cancer Treat Rep; 1981; 65 Suppl 3():43-56. PubMed ID: 6179615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
